Lagoda Investment Management’s AbbVie ABBV Stock Holding History

Lagoda Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-489	Closed	-$47K	–	39
2017 Q4	$47K	Hold	489	–	–	0.02%	37
2017 Q3	$43K	Hold	489	–	–	0.02%	38
2017 Q2	$35K	Buy	489 +163	+50%	+$11K	0.01%	36
2017 Q1	$21K	Sell	326 -163	-33%	-$10.2K	0.01%	34
2016 Q4	$31K	Sell	489 -2	-0.4%	-$122	0.01%	38
2016 Q3	$31K	Hold	491	–	–	0.01%	26
2016 Q2	$30K	Hold	491	–	–	0.01%	25
2016 Q1	$28K	Hold	491	–	–	0.01%	27
2015 Q4	$29K	Hold	491	–	–	0.01%	30
2015 Q3	$27K	Hold	491	–	–	0.01%	29
2015 Q2	$33K	Hold	491	–	–	0.01%	27
2015 Q1	$29K	Hold	491	–	–	0.01%	28
2014 Q4	$32K	Buy	+491	New	+$31K	0.01%	39

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lagoda Investment Management's ABBV Position: Q1 2018 in Review

Lagoda Investment Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 489 shares — an estimated $47K sold.

Lagoda Investment Management first reported a position in ABBV in Q4 2014 and held it in 13 quarters. The position peaked at $47K in Q4 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Lagoda Investment Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Lagoda Investment Management sold 489 AbbVie shares in Q1 2018, an estimated $47K.
Lagoda Investment Management first reported a position in AbbVie in Q4 2014 and held it in 13 quarters.
Lagoda Investment Management's AbbVie position peaked at $47K in Q4 2017.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Lagoda Investment Management's 13F filing for Q1 2018, filed 15 May 2018.